We’re Crowdfunding. Own a Piece of True Leaf. Click Here.

True Leaf Begins Trading on OTCQB Under “TRLFF” Symbol

July 20, 2017

True Leaf Begins Trading on OTCQB Under “TRLFF” Symbol

Vancouver, BC, July 20, 2017 – True Leaf Medicine International Ltd. (the “Company”) (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF) is pleased to announce that its common shares have begun trading on the OTC Market Group’s OTCQB® Venture Market under the ticker symbol “TRLFF”. The Company’s common shares will continue to trade on the Canadian Securities Exchange under the symbol “MJ” and on the Frankfurt Stock Exchange under the symbol “TLA”.
 
The OTCQB® Venture Market gives Canadian companies broad access to the U.S. investment community while maintaining standards that result in improved investor confidence and providing a seamless information flow from the Canadian Securities Exchange to the OTCQB.
 
“In response to growing investor interest in the United States, we have chosen to have True Leaf’s shares trade on the OTCQB instead of the OTC Pink tier, with greater exposure and accessibility to our expanding American and international shareholder base,” stated Darcy Bomford, President and CEO of the Company. “We look forward to further expansion of our shareholder base with this event.”
 
In addition, effective July 13, 2017, the Company received FINRA approval to change its OTC ticker symbol to ticker from “TLFMF” to “TRLFF”.
 
About True Leaf:
 
True Leaf Medicine International Ltd., through its wholly-owned subsidiary ‘True Leaf Pet’, has entered the $104.9 billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States, and Europe. The Company has also filed an application under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer through its ‘True Leaf Medicine’ subsidiary. It has passed through the security screening process of Health Canada’s review and is currently in the final review stage before the ‘pre-licensing inspection’ approval.
 
For more information, please see the Company’s website at www.trueleaf.com.
 
Investor Contact:
Kevin Bottomley
Director and Corporate Relations
kevin@trueleaf.com
M: 778-389-9933
 
Media Contact:
Paul Sullivan
BreakThrough Communications
p.sullivan@breakthroughpr.com
O: 604-685-4742
M: 604-603-7358
 
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS PRESS RELEASE.
 
Forward-Looking Information:
 
This press release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks discussed in the Company’s continuous disclosure filings available under the Company's profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.



Also in News

True Leaf Pet Expands Selling Power  In-Store and Online
True Leaf Pet Expands Selling Power In-Store and Online

September 07, 2017

Vancouver, Canada – (September 6, 2017) – True Leaf Pet, a division of True Leaf Medicine International Ltd. (MJ: CSE) (TLA: FSE) (TRLFF: OTCQB), has – in the span of a week – significantly expanded the  distribution of its popular True Hemp™ supplement line both online and in bricks and mortar stores.

Continue Reading

True Leaf Reaches Final Stage to Acquire License to Produce Marijuana in Canada
True Leaf Reaches Final Stage to Acquire License to Produce Marijuana in Canada

July 19, 2017

The True Leaf team has reached an incredible milestone. True Leaf Medicine Inc., a division of True Leaf Medicine International Ltd. (MJ: CSE) (TLA: FSE) (TRLFF: OTCQB), is in the final stage of the process to acquire a license to produce marijuana in Canada.

Continue Reading

True Leaf Announces First Tranche Closing of Private Placement and Stock Option Grants
True Leaf Announces First Tranche Closing of Private Placement and Stock Option Grants

May 30, 2017

True Leaf Medicine International Ltd. (the "Company") (MJ: CSE)(TLA: FSE) is pleased to announce that it has closed the first tranche of its recently-announced non-brokered private placement...

Continue Reading